Armed oncolytic viruses: A kick-start for anti-tumor immunity

被引：136

作者：

de Graaf, J. F. ^{[1
]}

de Vor, L. ^{[1
,2
]}

Fouchier, R. A. M. ^{[1
]}

van den Hoogen, B. G. ^{[1
]}

机构：

[1] Erasmus MC, Dept Virosci, Rotterdam, Netherlands

[2] UMC, Dept Microbiol, Utrecht, Netherlands

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2018年 / 41卷

关键词：

Oncolytic viruses; Immune therapy; Transgenes; NEWCASTLE-DISEASE-VIRUS; HERPES-SIMPLEX-VIRUS; VESICULAR STOMATITIS-VIRUS; COLONY-STIMULATING FACTOR; VACCINIA VIRUS; GM-CSF; CHECKPOINT BLOCKADE; EXPRESSING IL-12; SOLUBLE B7-1; T-CELLS;

D O I：

10.1016/j.cytogfr.2018.03.006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

070307 [化学生物学]; 071010 [生物化学与分子生物学];

摘要：

Oncolytic viruses (OVs), viruses that specifically result in killing tumor cells, represent a promising class of cancer therapy. Recently, the focus in the OV therapy field has shifted from their direct oncolytic effect to their immune stimulatory effect. OV therapy can function as a "kick start" for the antitumor immune response by releasing tumor associated antigens and release of inflammatory signals. Combining OVs with immune modulators could enhance the efficacy of both immune and OV therapies. Additionally, genetic engineering of OVs allows local expression of immune therapeutics, thereby reducing related toxicities. Different options to modify the tumor microenvironment in combination with OV therapy have been explored. The possibilities and obstacles of these combinations will be discussed in this review.

引用

页码：28 / 39

页数：12

共 131 条

[1]

Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer [J].

Aida, Kouichirou ;

Miyakawa, Reina ;

Suzuki, Koji ;

Narumi, Kenta ;

Udagawa, Takeshi ;

Yamamoto, Yuki ;

Chikaraishi, Tatsuya ;

Yoshida, Teruhiko ;

Aoki, Kazunori .

CANCER SCIENCE, 2014, 105 (02) :159-167

[2]

Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts [J].

Andarini, S ;

Kikuchi, T ;

Nukiwa, M ;

Pradono, P ;

Suzuki, T ;

Ohkouchi, S ;

Inoue, A ;

Maemondo, M ;

Ishii, N ;

Saijo, Y ;

Sugamura, K ;

Nukiwa, T .

CANCER RESEARCH, 2004, 64 (09) :3281-3287

[3]

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].

Andtbacka, Robert H. I. ;

Kaufman, Howard L. ;

Collichio, Frances ;

Amatruda, Thomas ;

Senzer, Neil ;

Chesney, Jason ;

Delman, Keith A. ;

Spitler, Lynn E. ;

Puzanov, Igor ;

Agarwala, Sanjiv S. ;

Milhem, Mohammed ;

Cranmer, Lee ;

Curti, Brendan ;

Lewis, Karl ;

Ross, Merrick ;

Guthrie, Troy ;

Linette, Gerald P. ;

Daniels, Gregory A. ;

Harrington, Kevin ;

Middleton, Mark R. ;

Miller, Wilson H., Jr. ;

Zager, Jonathan S. ;

Ye, Yining ;

Yao, Bin ;

Li, Ai ;

Doleman, Susan ;

VanderWalde, Ari ;

Gansert, Jennifer ;

Coffin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98

[4]

Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy [J].

Bai, Fuliang ;

Niu, Zeshan ;

Tian, Hui ;

Li, Siming ;

Lv, Zheng ;

Zhang, Tianyuan ;

Ren, Guiping ;

Li, Deshan .

IMMUNOLOGY LETTERS, 2014, 159 (1-2) :36-46

[5]

Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy [J].

Bartee, Mee Y. ;

Dunlap, Katherine M. ;

Bartee, Eric .

CANCER RESEARCH, 2017, 77 (11) :2952-2963

[6]

Oncolytic viruses as therapeutic cancer vaccines [J].

Bartlett, David L. ;

Liu, Zuqiang ;

Sathaiah, Magesh ;

Ravindranathan, Roshni ;

Guo, Zongbi ;

He, Yukai ;

Guo, Zong Sheng .

MOLECULAR CANCER, 2013, 12

[7]

Bourgeois-Daigneault M.-C., MOL THER, V3

[8]

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans [J].

Bramante, Simona ;

Kaufmann, Johanna K. ;

Veckman, Ville ;

Liikanen, Ilkka ;

Nettelbeck, Dirk M. ;

Hemminki, Otto ;

Vassilev, Lotta ;

Cerullo, Vincenzo ;

Oksanen, Minna ;

Heiskanen, Raita ;

Joensuu, Timo ;

Kanerva, Anna ;

Pesonen, Sari ;

Matikainen, Sampsa ;

Vaha-Koskela, Markus ;

Koski, Anniina ;

Hemminki, Akseli .

INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (07) :1775-1783

[9]

L-arginine metabolism in myeloid cells controls T-lymphocyte functions [J].

Bronte, V ;

Serafini, P ;

Mazzoni, A ;

Segal, DM ;

Zanovello, P .

TRENDS IN IMMUNOLOGY, 2003, 24 (06) :302-306

[10]

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma [J].

Buijs, Pascal ;

van Nieuwkoop, Stefan ;

Vaes, Vincent ;

Fouchier, Ron ;

van Eijck, Casper ;

van den Hoogen, Bernadette .

VIRUSES-BASEL, 2015, 7 (06) :2980-2998

← 1 2 3 4 5 6 7 8 9 10 →